Facilitating informed decisions regarding microsatellite instability testing among high-risk individuals diagnosed with colorectal cancer.

PURPOSE To evaluate the impact of a CD-ROM intervention in the education of patients with suspected Lynch syndrome (LS) about microsatellite instability (MSI) and immunohisochemistry (IHC) testing. PATIENTS AND METHODS Two hundred thirteen patients meeting Bethesda criteria were randomly assigned to receive either a brief educational session with a health educator (n = 105) or a brief educational session plus a CD-ROM (n = 108). Assessments were administered at baseline and 2 weeks post-treatment. Primary outcomes included MSI and IHC knowledge and level of satisfaction with and completeness of the preparation to make the decision for MSI testing. Secondary outcomes included decisional conflict, difficulty making the decision, cancer-specific and global anxiety, and level of discussion about MSI testing with family and friends. RESULTS Participants in the education plus CD-ROM condition reported significant increases in knowledge about the MSI and IHC tests, greater satisfaction with the preparation to make a decision for testing, lower decisional conflict, and greater decisional self-efficacy. The effects of the education plus CD-ROM on most outcomes were not moderated by preintervention levels of exposure to MSI testing, family support for MSI testing, or the family history of cancer. CONCLUSION Incorporation of new media education strategies for individuals at risk for LS may be a valuable component of the informed consent process. As clinical criteria for MSI and IHC testing continue to expand, the need for alternative educational approaches to meet this increased demand could be met by the self-administered computer-based strategy that we described.

[1]  Jeffrey R. Botkin,et al.  Summary of Recommendations: The Evaluation of Genomic Applications , 2022 .

[2]  C. Boland,et al.  A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. , 1997, Journal of the National Cancer Institute.

[3]  Daniel J Sargent,et al.  Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. , 2003, The New England journal of medicine.

[4]  M D Schwartz,et al.  Coping disposition, perceived risk, and psychological distress among women at increased risk for ovarian cancer. , 1995, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[5]  A. Finset,et al.  A new, brief questionnaire (PEQ) developed in primary health care for measuring patients' experience of interaction, emotion and consultation outcome. , 2001, Family practice.

[6]  K. McPherson,et al.  Cancer patients' information needs and information seeking behaviour: in depth interview study , 2000, BMJ : British Medical Journal.

[7]  Heather Hampel,et al.  Feasibility of screening for Lynch syndrome among patients with colorectal cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  Judi Homewood,et al.  Randomized trial of a decision aid for individuals considering genetic testing for hereditary nonpolyposis colorectal cancer risk , 2008, Cancer.

[9]  Lenora E. Johnson,et al.  Impact of educational print materials on knowledge, attitudes, and interest in BRCA1/BRCA2 , 2001, Cancer.

[10]  Helena Motlagh,et al.  Impact of Event Scale-revised. , 2010, Journal of physiotherapy.

[11]  M. Leppert,et al.  The colon cancer burden of genetically defined hereditary nonpolyposis colon cancer. , 2001, Gastroenterology.

[12]  J. Mecklin,et al.  The International Collaborative Group on HNPCC. , 1994, Anticancer research.

[13]  W. Frankel,et al.  Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. , 2006, Cancer research.

[14]  B. Biesecker,et al.  An interactive computer program can effectively educate patients about genetic testing for breast cancer susceptibility. , 2001, American journal of medical genetics.

[15]  B. Rosen,et al.  Development and testing of a decision aid for breast cancer prevention for women with a BRCA1 or BRCA2 mutation , 2007, Clinical genetics.

[16]  A. Rustgi,et al.  The Hereditary Nonpolyposis Colorectal Cancer Syndrome: Genetics and Clinical Implications , 2003, Annals of Internal Medicine.

[17]  N. Fost,et al.  Who should provide genetic education prior to gene testing? Computers and other methods for improving patient understanding. , 1997, Genetic testing.

[18]  Monica R McClain,et al.  EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome , 2009, Genetics in Medicine.

[19]  D. Chung,et al.  Knowledge and Attitudes about Microsatellite Instability Testing among High-Risk Individuals Diagnosed with Colorectal Cancer , 2007, Cancer Epidemiology Biomarkers & Prevention.

[20]  A. O'Connor,et al.  Validation of client decision-making instruments in the context of psychiatry. , 1996, The Canadian journal of nursing research = Revue canadienne de recherche en sciences infirmieres.

[21]  Floyd J. Fowler,et al.  A Randomized Trial of a Multimedia Shared Decision-Making Program for Men Facing a Treatment Decision for Benign Prostatic Hyperplasia , 1997 .

[22]  P Tugwell,et al.  A decision aid for women considering hormone therapy after menopause: decision support framework and evaluation. , 1998, Patient education and counseling.

[23]  A. O'Connor Validation of a Decisional Conflict Scale , 1995, Medical decision making : an international journal of the Society for Medical Decision Making.

[24]  I D Graham,et al.  Decision aids for patients considering options affecting cancer outcomes: evidence of efficacy and policy implications. , 1999, Journal of the National Cancer Institute. Monographs.

[25]  A. de la Chapelle,et al.  Hereditary Colorectal Cancer , 2010 .

[26]  R. Fodde,et al.  Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. , 1996, Gastroenterology.

[27]  R. Thomson,et al.  Decision aids for people facing health treatment or screening decisions. , 2003, The Cochrane database of systematic reviews.